Literature DB >> 9568962

Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein.

A V Timofeev1, S V Ozherelkov, A V Pronin, A V Deeva, G G Karganova, L B Elbert, J R Stephenson.   

Abstract

The humoral immune response to flaviviruses is mainly directed to the major envelope protein, E, and a glycosylated non-structural protein, NS1. Cell-mediated immune responses, however, appear to be directed mainly against non-structural proteins. Experiments described here show that a defective recombinant adenovirus (Rad51) containing the gene encoding the NS1 protein of tick-borne encephalitis virus can induce a strong protective immune response against several pathogenic tick-borne flaviviruses in an experimental animal model, and can enhance the efficacy of conventional vaccine preparations. A protective immune response against a lethal virus challenge can also be induced by the passive transfer of antibodies, B cells or T cells from animals vaccinated with Rad51. Raised levels of non-neutralizing antibodies and cytokines associated with a T helper cell-type 1 immune response are also observed. These data demonstrate the importance of non-structural viral proteins in the protective immune response against flaviviruses and support the use of non-structural viral proteins as vaccine components.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9568962     DOI: 10.1099/0022-1317-79-4-689

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  10 in total

1.  Genetic vaccination of mice with plasmids encoding the NS1 non-structural protein from tick-borne encephalitis virus and dengue 2 virus.

Authors:  A V Timofeev; V M Butenko; J R Stephenson
Journal:  Virus Genes       Date:  2004-01       Impact factor: 2.332

2.  Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms.

Authors:  Kyung Min Chung; Grant E Nybakken; Bruce S Thompson; Michael J Engle; Anantha Marri; Daved H Fremont; Michael S Diamond
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Two complex, adenovirus-based vaccines that together induce immune responses to all four dengue virus serotypes.

Authors:  David H Holman; Danher Wang; Kanakatte Raviprakash; Nicholas U Raja; Min Luo; Jianghui Zhang; Kevin R Porter; John Y Dong
Journal:  Clin Vaccine Immunol       Date:  2006-12-27

4.  Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.

Authors:  Eun Hye Kim; Hae-Jung Park; Gye-Yeong Han; Man-Ki Song; Alexander Pereboev; Jeong S Hong; Jun Chang; Young-Ho Byun; Baik Lin Seong; Huan H Nguyen
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

5.  Meta-analysis of all immune epitope data in the Flavivirus genus: inventory of current immune epitope data status in the context of virus immunity and immunopathology.

Authors:  Kerrie Vaughan; Jason Greenbaum; Martin Blythe; Bjoern Peters; Alessandro Sette
Journal:  Viral Immunol       Date:  2010-06       Impact factor: 2.257

6.  Protective immunity to Japanese encephalitis virus associated with anti-NS1 antibodies in a mouse model.

Authors:  Yize Li; Dorian Counor; Peng Lu; Veasna Duong; Yongxin Yu; Vincent Deubel
Journal:  Virol J       Date:  2012-07-24       Impact factor: 4.099

7.  An antivector vaccine protects against a lethal vector-borne pathogen.

Authors:  Milan Labuda; Adama R Trimnell; Martina Licková; Mária Kazimírová; Gillian M Davies; Olga Lissina; Rosie S Hails; Patricia A Nuttall
Journal:  PLoS Pathog       Date:  2006-04-07       Impact factor: 6.823

Review 8.  Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses.

Authors:  Mohammad Shoushtari; Farzin Roohvand; Mostafa Salehi-Vaziri; Arash Arashkia; Hasan Bakhshi; Kayhan Azadmanesh
Journal:  Hum Vaccin Immunother       Date:  2022-06-17       Impact factor: 4.526

Review 9.  Flavivirus NS1 and Its Potential in Vaccine Development.

Authors:  Kassandra L Carpio; Alan D T Barrett
Journal:  Vaccines (Basel)       Date:  2021-06-09

10.  Combined prime-boost vaccination against tick-borne encephalitis (TBE) using a recombinant vaccinia virus and a bacterial plasmid both expressing TBE virus non-structural NS1 protein.

Authors:  S E Aleshin; A V Timofeev; M V Khoretonenko; L G Zakharova; G V Pashvykina; J R Stephenson; A M Shneider; A D Altstein
Journal:  BMC Microbiol       Date:  2005-08-02       Impact factor: 3.605

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.